Initiating Pharmacologic Treatment in Tobacco-Dependent Adults

Alejandra Ellison-Barnes; Panagis Galiatsatos

doi:10.1016/j.mcna.2022.07.008

Initiating Pharmacologic Treatment in Tobacco-Dependent Adults

Med Clin North Am. 2022 Nov;106(6):1067-1080. doi: 10.1016/j.mcna.2022.07.008. Epub 2022 Oct 4.

Authors

Alejandra Ellison-Barnes¹, Panagis Galiatsatos²

Affiliations

¹ The Tobacco Treatment and Cancer Screening Clinic, The Johns Hopkins Health System, Baltimore, MD, USA; Division of General Internal Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, USA.
² The Tobacco Treatment and Cancer Screening Clinic, The Johns Hopkins Health System, Baltimore, MD, USA; Division of Pulmonary and Critical Care Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: panagis@jhmi.edu.

PMID: 36280333
DOI: 10.1016/j.mcna.2022.07.008

Abstract

There is a strong evidence base for the use of existing pharmacotherapies to support tobacco cessation, alone or in combination, ideally with concurrent behavioral interventions. Future pharmacotherapies under development may assist in the most refractory cases. Incorporating current and future therapies into a longitudinal chronic care model for tobacco dependence will help a diverse range of patients achieve independence from nicotine addiction.

Keywords: Nicotine addiction; Pharmacotherapy; Smoking cessation; Tobacco dependence.

Publication types

Review

MeSH terms

Humans
Nicotiana
Smoking Cessation*
Tobacco Use Cessation Devices
Tobacco Use Disorder* / drug therapy